Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

MSCV-FlagmuEzh2deltaset-Hygro Citations (2)

Originally described in: MSCV-FlagmusEzh2deltaSET-Hygro
Unpublished

Articles Citing MSCV-FlagmuEzh2deltaset-Hygro

Articles
Combined HAT/EZH2 modulation leads to cancer-selective cell death. Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-Megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L. Oncotarget. 2018 May 22;9(39):25630-25646. doi: 10.18632/oncotarget.25428. eCollection 2018 May 22. PubMed
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Verma A, Singh A, Singh MP, Nengroo MA, Saini KK, Satrusal SR, Khan MA, Chaturvedi P, Sinha A, Meena S, Singh AK, Datta D. Nat Commun. 2022 Nov 29;13(1):7344. doi: 10.1038/s41467-022-35059-x. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.